Seattle & Northwest CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Bothell Biotech, R&D Facility Receives $20M Refi
Connect Seattle is set for November 7th at Coterie Worklounge. Plan to join us for the afternoon of CRE conversations and networking. You can find out more information and register on this link.
JLL arranged a $19.92 million refinancing for Nexus Canyon Park Research Center, a 152,050-square-foot Life Science/Flex/R&D building in Bothell. The borrower was San Diego-based Nexus Properties, Inc., and the loan was placed with a national lender.
The asset is located at 21720 23rd Dr. SE in the Seattle-Bellevue region’s Eastside office market, one of the Puget Sound’s largest and most active office markets with 52.4 million square feet of inventory. Situated within the Canyon Park Business Center, the property is just north of Interstate 405, roughly 15 miles northeast of downtown Seattle.
Completed in 1999, the two-story facility recently underwent a partial conversion of space into flex industrial that provides for the potential to appeal to a variety of lab, office and flex users. Current tenants include Epoch Pharmaceuticals, Sony Biotechnology, Inc., Sound Biologics and Shimadzu Scientific.
JLL’s Tim Wright, Zack Holderman, Zack Goodwin, and Anthony Rosetta represented the borrower.
For comments, questions or concerns, please contact Dennis Kaiser
- ◦Financing
